Trial · NCT00977197
Results by group28
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 28
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Pain Bowel Symptom Scale (BSS) Score Over Last 4 Weeks of Study (Weeks 9-12) | Pregabalin | 25.3 | Standard Deviation 16.0 | units on a scale | |
| Mean Pain Bowel Symptom Scale (BSS) Score Over Last 4 Weeks of Study (Weeks 9-12) | Placebo | 42.0 | Standard Deviation 26.6 | units on a scale | |
| Mean Overall Severity of Irritable Bowel Syndrome (IBS) Symptoms BSS Score Last 4 Weeks of the Study (Weeks 9-12) | Pregabalin | 26.5 | Standard Deviation 15.2 | units on a scale | |
| Mean Overall Severity of Irritable Bowel Syndrome (IBS) Symptoms BSS Score Last 4 Weeks of the Study (Weeks 9-12) | Placebo | 42.2 | Standard Deviation 25.7 | units on a scale | |
| Mean Constipation BSS Score Over Last 4 Weeks of Study (Weeks 9-12) | Pregabalin | 25.8 | Standard Deviation 26.8 | units on a scale | |
| Mean Constipation BSS Score Over Last 4 Weeks of Study (Weeks 9-12) | Placebo | 22.4 | Standard Deviation 24.8 | units on a scale | |
| Mean Diarrhea BSS Score Over the Last 4 Weeks of the Study (Weeks 9-12) | Pregabalin | 16.9 | Standard Deviation 18.4 | units on a scale | |
| Mean Diarrhea BSS Score Over the Last 4 Weeks of the Study (Weeks 9-12) | Placebo | 31.8 | Standard Deviation 25.8 | units on a scale | |
| Mean Bloating BSS Score Over the Last 4 Weeks of the Study (Weeks 9-12) | Pregabalin | 29.3 | Standard Deviation 23.3 | units on a scale | |
| Mean Bloating BSS Score Over the Last 4 Weeks of the Study (Weeks 9-12) | Placebo | 43.6 | Standard Deviation 29.0 | units on a scale | |
| Number of Subjects With Adequate Relief of IBS Symptoms at Least 50% of the Last 4 Weeks of Therapy | Pregabalin | Adequate Relief (Yes) | 19 | participants | |
| Number of Subjects With Adequate Relief of IBS Symptoms at Least 50% of the Last 4 Weeks of Therapy | Placebo | Adequate Relief (Yes) | 16 | participants | |
| Number of Subjects With Adequate Relief of IBS Symptoms at Least 50% of the Last 4 Weeks of Therapy | Pregabalin | Inadequate Relief (No) | 22 | participants | |
| Number of Subjects With Adequate Relief of IBS Symptoms at Least 50% of the Last 4 Weeks of Therapy | Placebo | Inadequate Relief (No) | 28 | participants | |
| Mean Pain BSS Score at Week 12 | Pregabalin | 26.1 | Standard Deviation 18.8 | units on a scale | |
| Mean Pain BSS Score at Week 12 | Placebo | 43.3 | Standard Deviation 30 | units on a scale | |
| Mean Overall Severity BSS Score at Week 12 | Pregabalin | 28.5 | Standard Deviation 20.2 | units on a scale | |
| Mean Overall Severity BSS Score at Week 12 | Placebo | 44.2 | Standard Deviation 28.8 | units on a scale | |
| Mean Constipation BSS Score at Week 12 | Pregabalin | 26.1 | Standard Deviation 30.4 | units on a scale | |
| Mean Constipation BSS Score at Week 12 | Placebo | 23.6 | Standard Deviation 26.7 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00977197/results